RESUMO
RATIONALE: Fatty acids and sterol lipids play crucial roles in several biological processes and several biological facts underline the interconnection between these lipid classes. Therefore, it is of interest to develop a comprehensive method analysing both classes in the form of their most favourable derivatives suitable for quantification and isotopologue analysis. METHODS: Lipids were derivatised by a sequential one-pot procedure using N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MtBSTFA) and N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA). No clean-up or concentration steps were necessary. The prepared samples were directly available for gas chromatography-electron ionisation mass spectrometric (GC-EI-MS) analysis on a standard column. For quantification, the SIM mode was used and for isotopologue analysis scheduled scan mode was applied. RESULTS: Development of a sequential one-pot derivatisation for GC-EI-MS allowing comprehensive analysis of fatty acids and sterols as their most favourable derivatives. Validation carried out using human plasma, comparison with certified NIST plasma. LLOQ of usually 3.3 ng/mL achieved. Isotopologue analysis of 2-[(13)C]-acetate incorporation in HL-60 cells proving feasibility of method. CONCLUSIONS: The presented method successfully combines two consecutive silylation reactions in one pot, enabling the analysis of both fatty acids and sterols in a comprehensive analytical method. The method has great potential for the quantification of lipids as well as the comprehensive study of both biochemical pathways, using [(13)C]-flux analysis.
Assuntos
Ácidos Graxos/análise , Cromatografia Gasosa-Espectrometria de Massas/métodos , Esteróis/análise , Ácidos Graxos/química , Células HL-60 , Humanos , Isótopos/análise , Isótopos/química , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Esteróis/químicaRESUMO
Flow-through electrochemical conversion (EC) of drug-like molecules was hyphenated to miniaturized nuclear magnetic resonance spectroscopy (NMR) via on-line solid-phase extraction (SPE). After EC of the prominent p38α mitogen-activated protein kinase inhibitor BIRB796 into its reactive products, the SPE step provided preconcentration of the EC products and solvent exchange for NMR analysis. The acquisition of NMR spectra of the mass-limited samples was achieved in a stripline probe with a detection volume of 150 nL offering superior mass sensitivity. This hyphenated EC-SPE-stripline-NMR setup enabled the detection of the reactive products using only minute amounts of substrate. Furthermore, the integration of conversion and detection into one flow setup counteracts incorrect assessments caused by the degradation of reactive products. However, apparent interferences of the NMR magnetic field with the EC, leading to a low product yield, so far demanded relatively long signal averaging. A critical assessment of what is and what is not (yet) possible with this approach is presented, for example in terms of structure elucidation and the estimation of concentrations. Additionally, promising routes for further improvement of EC-SPE-stripline-NMR are discussed.
Assuntos
Eletroquímica/instrumentação , Análise de Injeção de Fluxo/métodos , Espectroscopia de Ressonância Magnética/instrumentação , Proteína Quinase 14 Ativada por Mitógeno/análise , Proteína Quinase 14 Ativada por Mitógeno/química , Extração em Fase Sólida/instrumentação , Desenho de Equipamento , Análise de Falha de Equipamento , Estudos de Viabilidade , Miniaturização , Reprodutibilidade dos Testes , Sensibilidade e EspecificidadeRESUMO
Fast analytical methodologies are mandatory for large scale metabolic profiling. Here, we present a thorough evaluation of different column chemistries in combination with different mobile phases for fast LC-MS urinary metabolic profiling. Three porous HILIC materials were investigated, next to core-shell C18-, XB-C18- and PFP-RPLC material. The performance of the selected column chemistries was tested in a non-targeted manner with pooled urine samples and in a targeted manner with a set of 54 common urinary metabolites. In order to evaluate the differential behaviour of the tested columns in a targeted manner, we applied a peak scoring algorithm. This algorithm takes into account several quality criteria such as retention time, dead time, peak height and peak shape. In general, HILIC columns generate more retention for polar metabolites. Our results show that the diol-HILIC column outperforms the RPLC columns. However, because of their opposite nature, comprehensive behaviour is observed as well, which was shown by investigating gender differences in a small urinary sample set. All applied column chemistries enabled sufficient peak capacity within a short gradient time.
Assuntos
Biomarcadores/urina , Cromatografia Líquida/instrumentação , Cromatografia Líquida/métodos , Metabolômica/métodos , Urina/química , Algoritmos , Biomarcadores/metabolismo , Feminino , Humanos , Masculino , Espectrometria de Massas , MetabolomaRESUMO
Venomous snakes have evolved their efficient venomous arsenals mainly to immobilize prey. The highly variable toxic peptides in these venoms target a myriad of neurotoxic and haemotoxic receptors and enzymes and comprise highly interesting candidates for drug discovery. Discovery of bioactive compounds from snake venoms, however, is a challenge to achieve. We have developed and applied a methodology to rapidly assess bioactives in a snake venom proteome. Our microfluidic platform opens up efficient and rapid profiling of venomous anti-cholinergic receptor compounds. The key advantages of our methodology are: (i) nano amounts of venom needed; and (ii) a direct correlation of selected bioaffinities with accurate mass. To achieve this, we have for the first time successfully constructed a functional post nano-LC split to MS and bioaffinity profiling. In our method, comprehensive venom profiles with accurate masses and corresponding bioaffinities are obtained in one analytical run and will subsequently allow immediate purification of bioactive peptides with LC-MS, guided by accurate masses of the bioactives only. We profiled several neurotoxic Elapidae snake venoms using our methodology in combination with the acetylcholine binding protein (AChBP) as biological target protein. The latter is a homologue of nicotinic acetylcholine receptors (nAChRs), a drug target in neurodegenerative diseases and cognitive decline such as Parkinson's and Alzheimer's, and in pain related diseases. Our methodology was evaluated and validated with high-affinity α-bungarotoxin and haemotoxic/proteolytic Vipera ammodytes venom spiked with α-bungarotoxin. Thereafter, the methodology was applied to profile the venom proteomes of Dendroaspis jamesoni kaimosae, Naja annulifera and Naja nivea. Gathering comprehensive profiling data took less than 2 h per snake venom measured. The data yielded 20 AChBP ligands of which the corresponding accurate masses were used to retrieve information from literature regarding their function and targeting specificity. We found that from these 20 ligands, 11 were previously reported on, while information on the others could not be found. From these 11 peptides, five have been reported to have nAChR affinity, while the others are reported as cytotoxic, cardiotoxic or as orphan toxin. Our methodology has the potential to aid the field of profiling complex animal venoms for drug discovery.
Assuntos
Técnicas Analíticas Microfluídicas/métodos , Neurotoxinas/farmacologia , Receptores Nicotínicos/efeitos dos fármacos , Venenos de Serpentes/farmacologia , Animais , Avaliação Pré-Clínica de Medicamentos , Venenos Elapídicos/farmacologia , Humanos , Lymnaea , Microscopia Confocal , Espectrometria de Massas por Ionização por Electrospray , Venenos de Víboras/farmacologiaRESUMO
Malondialdehyde (MDA) is an end-product of lipid peroxidation and a side product of thromboxane A(2) synthesis. Moreover, it is not only a frequently measured biomarker of oxidative stress, but its high reactivity and toxicity underline the fact that this molecule is more than "just" a biomarker. Additionally, MDA was proven to be a mutagenic substance. Having said this, it is evident that there is a major interest in the highly selective and sensitive analysis of this molecule in various matrices. In this review, we will provide a brief overview of the most recent developments and techniques for the liquid chromatography (LC) and gas chromatography (GC)-based analysis of MDA in different matrices. While the 2-thiobarbituric acid assay still is the most prominent methodology for determining MDA, several advanced techniques have evolved, including GC-MS(MS), LC-MS(MS) as well as several derivatization-based strategies.
RESUMO
This study describes the evaluation, validation, and use of contactless postcolumn fractionation of bioactive mixtures with acetylcholine binding protein (AChBP) affinity analysis with help of a spotter technology. The high-resolution fractionation tailors the fractionation frequency to the chromatographic peaks. Postcolumn reagents for AChBP bioaffinity profiling are mixed prior to droplet ejection into 1536-well plates. After an incubation step, microplate reader analysis is used to determine bioactive compounds in a mixture. For ligands tested, a good correlation was found for IC(50)s determined in flow injection analysis mode when compared with traditional radioligand binding assays. After the evaluation and validation, bioaffinity profiling of actual mixtures was performed. The advantage of this "atline" technology using postcolumn bioaffinity analysis when compared to continuous flow online postcolumn bioaffinity profiling is the possibility to choose postcolumn incubation times freely without compromising resolution due to diffusion effects.
Assuntos
Proteínas de Transporte , Cromatografia de Afinidade/métodos , Cromatografia Líquida de Alta Pressão/métodos , Misturas Complexas/análise , Análise de Injeção de Fluxo/métodos , Ensaios de Triagem em Larga Escala , Compostos Bicíclicos Heterocíclicos com Pontes/análise , Compostos Bicíclicos Heterocíclicos com Pontes/metabolismo , Proteínas de Transporte/química , Proteínas de Transporte/metabolismo , Fracionamento Químico/métodos , Cromatografia de Afinidade/instrumentação , Misturas Complexas/química , Análise de Injeção de Fluxo/instrumentação , Ligantes , Espectrometria de Massas/métodos , Nanotecnologia/métodos , Nicotina/análise , Nicotina/metabolismo , Agonistas Nicotínicos/análise , Agonistas Nicotínicos/metabolismo , Ligação Proteica , Piridinas/análise , Piridinas/metabolismo , Ensaio Radioligante , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Reprodutibilidade dos TestesRESUMO
In this paper we describe the hyphenation of high temperature liquid chromatography with ICP-MS and ESI-MS for the characterization of halogen containing drug metabolites. The use of temperature gradients up to 200°C enabled the separation of metabolites with low organic modifier content. This specific property allowed the use of detection methods that suffer from (significant) changes in analyte response factors as a function of the organic modifier content such as ICP-MS. Metabolites of two kinase inhibitors (SB-203580-Iodo and MAPK inhibitor VIII) produced by bacterial cytochrome P450 BM3 mutants and human liver microsomes were identified based on high resolution MS(n) data. Quantification was done using their normalized and elemental specific response in the ICP-MS. The importance of these kinds of quantification strategies is stressed by the observation that the difference of the position of one oxygen atom in a structure can greatly affect its response in ESI-MS and UV detection.
Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Halogênios/análise , Espectrometria de Massas/métodos , Preparações Farmacêuticas/análise , Bromo/análise , Bromo/química , Bromo/metabolismo , Feminino , Halogênios/química , Halogênios/metabolismo , Temperatura Alta , Humanos , Imidazóis/análise , Imidazóis/química , Imidazóis/metabolismo , Iodo/análise , Iodo/química , Iodo/metabolismo , Limite de Detecção , Masculino , Microssomos Hepáticos/química , Microssomos Hepáticos/metabolismo , Oxigênio/análise , Oxigênio/química , Oxigênio/metabolismo , Preparações Farmacêuticas/química , Preparações Farmacêuticas/metabolismo , Inibidores de Proteínas Quinases/análise , Inibidores de Proteínas Quinases/química , Inibidores de Proteínas Quinases/metabolismo , Piridinas/análise , Piridinas/química , Piridinas/metabolismo , Espectrometria de Massas por Ionização por Electrospray/métodosRESUMO
Malondialdehyde (MDA) has become a well-established biomarker for oxidative stress. The most commonly used way to determine urinary MDA levels is the thiobarbituric acid (TBA) assay, which suffers from several drawbacks. In this manuscript, we describe a novel derivatization strategy for the highly sensitive and selective fluorescence-based determination of MDA in urinary samples. The methodology is based on the mild labeling of MDA with 2-aminoacridone, which can be carried out in aqueous citrate buffer at 40 °C, yielding a highly fluorescent substance. No further sample preparation than mixing with the necessary chemicals is necessary. The formed MDA derivative can conveniently be separated from the label itself and matrix constituents by gradient LC in less than 5 minutes on a cyano-based reversed-phase material. The method was validated with respect to matrix effects, linearity, selectivity and sensitivity (values as low as 1.8 nM for the LOD and 5.8 nM for the LOQ could be achieved). Standard addition quantitation was applied for the determination of MDA in human urine samples. Additionally, the protocol was applied to the measurement of a stability indicating analysis of MDA in urine at different storage conditions.
Assuntos
Aminoacridinas/química , Malondialdeído/química , Malondialdeído/urina , Coloração e Rotulagem/métodos , Urinálise/métodos , Humanos , Concentração de Íons de Hidrogênio , Indicadores e Reagentes/química , Cinética , Limite de Detecção , Modelos Lineares , Masculino , Reprodutibilidade dos Testes , Espectrofotometria Ultravioleta , Especificidade por Substrato , TemperaturaRESUMO
A magnetic beads based affinity-selection methodology towards the screening of acetylcholine binding protein (AChBP) binders in mixtures and pure compound libraries was developed. The methodology works as follows: after in solution incubation of His-tagged AChBP with potential ligands, and subsequent addition of cobalt (II)-coated paramagnetic beads, the formed bead-AChBP-ligand complexes are fetched out of solution by injection and trapping in LC tubing with an external adjustable magnet. Non binders are then washed to the waste followed by elution of ligands to a SPE cartridge by flushing with denaturing solution. Finally, SPE-LC-MS analysis is performed to identify the ligands. The advantage of the current methodology is the in solution incubation followed by immobilized AChBP ligand trapping and the capability of using the magnetic beads system as mobile/online transportable affinity SPE material. The system was optimized and then successfully demonstrated for the identification of AChBP ligands injected as pure compounds and for the fishing of ligands in mixtures. The results obtained with AChBP as target protein demonstrated reliable discrimination between binders with pK(i) values ranging from at least 6.26 to 8.46 and non-binders.
Assuntos
Proteínas de Transporte/análise , Cromatografia Líquida/métodos , Descoberta de Drogas/métodos , Magnetismo , Microesferas , Extração em Fase Sólida/métodos , Proteínas de Transporte/química , Proteínas de Transporte/metabolismo , Desenho de Equipamento , Espectrometria de Massas , Preparações Farmacêuticas/química , Preparações Farmacêuticas/metabolismo , Ligação Proteica , Bibliotecas de Moléculas Pequenas/química , Bibliotecas de Moléculas Pequenas/metabolismoRESUMO
Galantamine hydrobromide was subjected to different stress conditions (acidic, alkaline, thermal, photolytic and oxidative). Degradation was found to occur under acidic, photolytic and oxidative conditions, while the drug was stable under alkaline and elevated temperature conditions. A stability-indicating reversed-phase liquid chromatographic method was developed for the determination of the drug in the presence of its degradation products. The method was validated for linearity, precision, accuracy, specificity, selectivity and intermediate precision. Additionally, the degradation kinetics of the drug was assessed in relevant cases. The kinetics followed a first order behavior in the case of acidic and photolytic degradation, while a two-phase kinetics behavior was found for the oxidative degradation. The degradation products were characterized by mass spectrometry and nuclear magnetic resonance spectroscopy. Dehydration, epimerization and N-oxidation were the main processes observed during the degradation of galantamine. Moreover, if sufficient material could be isolated the inhibitory activity against the target enzyme acetylcholinesterase was also assessed.
Assuntos
Inibidores da Colinesterase/química , Galantamina/química , Tecnologia Farmacêutica , Doença de Alzheimer/tratamento farmacológico , Inibidores da Colinesterase/análise , Inibidores da Colinesterase/farmacologia , Inibidores da Colinesterase/efeitos da radiação , Colinesterases/metabolismo , Cromatografia Líquida de Alta Pressão , Estabilidade de Medicamentos , Galantamina/análogos & derivados , Galantamina/farmacologia , Galantamina/efeitos da radiação , Temperatura Alta/efeitos adversos , Concentração de Íons de Hidrogênio , Cinética , Luz/efeitos adversos , Espectroscopia de Ressonância Magnética , Oxirredução , Fotólise , Reprodutibilidade dos Testes , Espectrometria de Massas por Ionização por Electrospray , Estereoisomerismo , Espectrometria de Massas em TandemRESUMO
Alzheimer's is a neurodegenerative disease. Its symptoms are attributed to a deficiency of cholinergic neurotransmission. The drugs of choice for the treatment of Alzheimer's disease are acetylcholinesterase (AChE) inhibitors. Starting in the 1980's from non-specific AChE inhibitors, the first-generation drugs such as physostigmine, a second generation of more selective and better tolerated products has been developed. Methods to detect and quantify these drugs and their metabolites in biological samples have been developed for analysis in plasma, blood, urine and cerebrospinal fluid. Diverse detection techniques have been used, such as ultraviolet, fluorescence, electrochemical and mass spectrometry. In this review, the methods applied to the analysis of these drugs and their metabolites in different biological matrices are reviewed and discussed. The stability of these drugs in biological matrices and under stress-conditions is also included in the discussion.
Assuntos
Inibidores da Colinesterase/análise , Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/metabolismo , Inibidores da Colinesterase/sangue , Inibidores da Colinesterase/química , Inibidores da Colinesterase/metabolismo , Estabilidade de Medicamentos , HumanosRESUMO
The development of a contactless postcolumn spotter technology capable of rapidly and accurately depositing LC eluent onto another platform (e.g., 1536-well microtiter plates) is described. Many detection methodologies are suitable for online analysis, such as mass spectrometry, UV-vis, and fluorescence. In some cases, when online analysis is less suitable, off-line postcolumn analysis is the methodology of choice and usually relies on LC-based fractionation prior to detection (e.g., MALDI-MS, Raman spectrsocopy, biochemical assays). As fractionation generally involves loss in resolution, the technology described here allows high-resolution contactless fractionation by tailoring the fractionation frequency to the chromatographic peaks and mixing in of postcolumn reagents. Droplet ejection at frequencies of at least 6 Hz could be performed in the nanoliter to low microliter range with repeatabilities of â¼6%. Furthermore, multiple droplets can be ejected at the same position thereby allowing adjustment of fractionation volume and speed. The technology was evaluated, optimized, and validated prior to two proof-of-principle demonstrations comprising off-line chemical detection of injected fluorescein and off-line postcolumn biochemical detection of acetylcholine-binding protein ligands, both based on 1536-well plate reader analysis.
Assuntos
Fracionamento Químico/métodos , Cromatografia Líquida/métodos , Nanotecnologia/métodos , Animais , Proteínas de Transporte/isolamento & purificação , Proteínas de Transporte/metabolismo , Linhagem Celular , Fracionamento Químico/instrumentação , Fluoresceína/química , Indicadores e Reagentes/química , Espectrometria de Massas , Nanotecnologia/instrumentação , Reprodutibilidade dos Testes , Fatores de TempoRESUMO
One way to profile complex mixtures for receptor affinity is to couple liquid chromatography (LC) on-line to biochemical detection (BCD). A drawback of this hyphenated screening approach is the relatively high consumption of sample, receptor protein and (fluorescently labeled) tracer ligand. Here, we worked toward minimization of sample and reagent consumption, by coupling nano-LC on-line to a light-emitting diode (LED) based capillary confocal fluorescence detection system capable of on-line BCD with low-flow rates. In this fluorescence detection system, a capillary with an extended light path (bubble cell) was used as a detection cell in order to enhance sensitivity. The technology was applied to a fluorescent enhancement bioassay for the acetylcholine binding protein, a structural analog of the extracellular ligand-binding domain of neuronal nicotinic acetylcholine receptors. In the miniaturized setup, the sensitive and low void volume LED-induced confocal fluorescence detection system operated in flow injection analysis mode allowing the measurement of IC(50) values, which were comparable with those measured by a conventional plate reader bioassay. The current setup uses 50 nL as injection volume with a carrier flow rate of 400 nL/min. Finally, coupling of the detection system to gradient reversed-phase nano-LC allowed analysis of mixtures in order to identify the bioactive compounds present by injecting 10 nL of each mixture.
Assuntos
Bioensaio/métodos , Cromatografia Líquida/métodos , Análise de Injeção de Fluxo/métodos , Microfluídica/métodos , Microscopia de Fluorescência/métodos , Bioensaio/instrumentação , Proteínas de Transporte/análise , Microfluídica/instrumentaçãoRESUMO
A new methodology is described enabling the affinity screening of potential ligands towards the human estrogen receptor alpha ligand binding domain (ERalpha-LBD). In-solution incubation is performed of the analyte and the His-tagged ERalpha-LBD. The bound complex is immobilized on a nickel-loaded protein-affinity selection column, where after the unbound fraction is removed. The immobilized protein-ligand complex is exposed to a decreased pH value and an increased organic modifier concentration releasing the ligand for MS detection, and precipitating the proteins on a filter positioned between the affinity column and the mass spectrometer. The trapping column can be regenerated for reuse at least 70 times. The advantages of the methodology over existing methodologies are the absence of a pre-concentration as well as a chromatographic separation step, resulting in a significantly shorter analysis time compared to previously described procedures, and in addition, allowing the determination of solutes with unfavorable chromatographic properties. The overall analysis time now can be reduced about 250% to approximately 6 min. Replacing the filters after every measurement results in an intra-day standard deviation of 14.8% and an inter-day standard deviation of 21.3%.
RESUMO
The acetylcholine binding protein (AChBP) is considered an analogue for the ligand-binding domain of neuronal nicotinic acetylcholine receptors (nAChRs). Its stability and solubility in aqueous buffer allowed the development of an online bioaffinity analysis system. For this, a tracer ligand which displays enhanced fluorescence in the binding pocket of AChBP was identified from a concise series of synthetic benzylidene anabaseines. Evaluation and optimization of the bioaffinity assay was performed in a convenient microplate reader format and subsequently transferred to the online format. The high reproducibility has the prospect of estimating the affinities of ligands from an in-house drug discovery library injected in one known concentration. Furthermore, the online bioaffinity analysis system could also be applied to mixture analysis by using gradient HPLC. This led to the possibility of affinity ranking of ligands in mixtures with parallel high-resolution mass spectrometry for compound identification.
Assuntos
Anabasina/análogos & derivados , Proteínas de Transporte/química , Anabasina/síntese química , Anabasina/química , Sítios de Ligação , Cromatografia Líquida , Descoberta de Drogas , Análise de Injeção de Fluxo , Fluorometria , Ligantes , Espectrometria de Massas/métodos , Ligação Proteica , Ensaio Radioligante , Reprodutibilidade dos TestesRESUMO
Over the years, many different high throughput screening technologies and subsequently follow-up methodologies have been developed. All of these can be categorized, for example according to measurement of analyte classes, assay mechanisms, readout principles, or screening of drug target classes. When categorized according to drug target class, assay formats can be subdivided into early hit stage assays (usually ligand-binding based) that are often straightforward and robust up to analysis of final cellular effects exerted by ligands. The latter do not only provide higher content data but also represent anticipated effects in the body more closely. These assay formats, however, are often also elaborate, non-robust, and very time consuming to conduct but become pivotal when going from the hit-to-lead discovery stage. Looking at the hit-to-lead process, new assay possibilities in terms of measured effects and readout principles are continuously reaching the screening arena. Furthermore, at the (early-) lead discovery stage other targets also have to be evaluated to study e.g. target selectivity and ADME(T). This review discusses many of the different assay formats used in the hit-to-lead discovery phase sorted by their use for screening major drug target classes for small molecule drug discovery. The receptor drug targets in this review are subdivided into GPCRs, nuclear receptors and ion channels, while for the enzyme drug targets the important protein kinases, proteases and the drug metabolism enzymes (CYPs; mainly important for drug metabolism and drug-drug interactions) are discussed in more detail. For every drug target, different assay formats used to analyze ligand mediated effects at specific points in the drug target's respective signal transduction cascade(s) are looked at. More specifically, assay methodologies for ligand binding and second messenger formation up to signal transduction cascades and analysis of eventual (cell based) effects are described. Furthermore, special attention is paid to less traditional (non-platereader based) state-of-the-art screening approaches such as LC-MS, microarrays, microfluidics and sensor based technologies.
Assuntos
Ensaios de Triagem em Larga Escala/métodos , Preparações Farmacêuticas/análise , Modelos Biológicos , Preparações Farmacêuticas/metabolismo , Transdução de SinaisRESUMO
The present paper describes a methodology for rapid assessment of chemical and biological degradation products of tacrine and their bioactivity for acetylcholinesterase (AChE). Analysis was achieved by utilizing liquid chromatography coupled to parallel high resolution mass spectrometry and an on-line continuous-flow AChE bioassay for biochemical detection. Key advantage of the strategy described involves the straightforward chemical production of large quantities of products of which many were the same as formed during the biological degradation by cytochromes P450 (CYPs). For this, chemical degradation of tacrine was evaluated under acidic, basic and oxidative conditions as well as elevated temperatures and light exposure. Chemical degradation products were only formed after 2h under reflux with 3% hydrogen peroxide, where more than 50% of tacrine was converted to degradation products. Many of these products showed bioactivity. Mostly, mono-, di- or tri-oxygenated compounds were observed. This study demonstrated that the combination of chemical and biological degradation provides valuable information indicating that assessment of biological activity is important not only for biological degradation products, but also for chemical degradation products when formed. Furthermore, chemical degradation can be used to produce conveniently and in relatively large quantities clean mixtures of compounds that are also produced during metabolic incubations.
Assuntos
Acetilcolinesterase/metabolismo , Tacrina/metabolismo , Acetilcolinesterase/química , Animais , Microssomos Hepáticos/metabolismo , Ratos , Suínos , Espectrometria de Massas em TandemRESUMO
Structural elucidation of six regioisomers of mono-N-octyl derivatized neomycin is achieved using MS(n) (up to n = 4) on an ion trap time-of-flight (IT-TOF) instrument equipped with electrospray ionization. The mixture of six derivatized neomycin analogues was generated by reductive amination in a shotgun synthetic approach. In parallel to the liquid chromatography/mass spectrometry (LC/MS) detection, the antibacterial activity of the neomycin regioisomers was tested by post-column addition of buffer and bacterial inocula, subsequent microfractionation of the resulting mixture, incubation, and finally a chemiluminescence-based bioactivity measurement based on the production of bacterial ATP. The MS-based high-resolution screening approach described can be applied in medicinal chemistry to help in designing and producing new antibiotic substances, which is particularly challenging due to the high functionality of most antibiotic substances, therefore requiring advanced (hyphenated) separation and detection techniques for compound mixtures.
Assuntos
Bioensaio/métodos , Cromatografia Líquida/métodos , Espectrometria de Massas/métodos , Neomicina/análogos & derivados , Trifosfato de Adenosina/metabolismo , Escherichia coli/efeitos dos fármacos , Testes de Sensibilidade Microbiana/métodos , Neomicina/química , Neomicina/metabolismo , Neomicina/farmacologia , EstereoisomerismoRESUMO
Based on the template of a recently introduced derivatization reagent for aldehydes, 4-(2-(trimethylammonio)ethoxy)benzeneaminium dibromide (4-APC), a new derivatization agent was designed with additional features for the analysis and screening of biomarkers of lipid peroxidation. The new derivatization reagent, 4-(2-((4-bromophenethyl)dimethylammonio)ethoxy)benzenaminium dibromide (4-APEBA) contains a bromophenethyl group to incorporate an isotopic signature to the derivatives and to add additional fragmentation identifiers, collectively enhancing the abilities for detection and screening of unknown aldehydes. Derivatization can be achieved under mild conditions (pH 5.7, 10 degrees C). By changing the secondary reagent (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide instead of sodium cyanoborohydride), 4-APEBA is also applicable to the selective derivatization of carboxylic acids. Synthesis of the new label, exploration of the derivatization conditions, characterization of the fragmentation of the aldehyde and carboxylic acid derivatives in MS/MS, and preliminary applications of the labeling strategy for the analysis of aldehydes in urine and plasma are described.
Assuntos
Aldeídos/análise , Biomarcadores/análise , Ácidos Carboxílicos/análise , Cromatografia Líquida/métodos , Peroxidação de Lipídeos , Espectrometria de Massas/métodos , Aldeídos/metabolismo , Compostos de Anilina/química , Biomarcadores/metabolismo , Ácidos Carboxílicos/metabolismo , Dimetilaminas/química , Humanos , Oxirredução , Plasma/metabolismoRESUMO
A new photoisomer of the promising "anti-Alzheimer" drug candidate (+/-) huperzine A is described. The new substance was formed via a photoisomerization reaction and was found to be 1-amino-13-ethylidene-11-methyl-6-aza-tetracyclo-[7.3.1.0(2.7).0(4.7)]-trideca-2,10-diene-5-one using NMR analysis. The kinetics of its formation was studied and proven to be of first-order. The described photoisomer showed a significant loss in activity, being more than 100 times less active than (-) huperzine A itself. The new substance was named photohuperzine A, referring to its photopyridone substructure.